Strides Pharma Science Limited has informed the Exchange regarding a press release dated August 30, 2023, titled "Strides receives USFDA approval for Mycophenolate Mofetil for Oral Suspension".
Strides Pharma Science Limited has informed the Exchange regarding a press release dated August 30, 2023, titled "Strides receives USFDA approval for Mycophenolate Mofetil for Oral Suspension".